Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 juin 2019 07h00 HE | Source: Orchestra BioMed

Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon

Virtue® SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its broad US and global portfolio of interventional solutionsTerms of the partnership include...
23 mai 2019 07h30 HE | Source: Orchestra BioMed

Orchestra BioMed™ Presents Clinical Data at EuroPCR 2019 Demonstrating Safety and Efficacy of BackBeat Cardiac Neuromodulation Therapy (CNT)

Novel implantable bioelectronic treatment delivers immediate, substantial, and sustained reduction in blood pressureData showed 14.2 mmHg reduction in 24-hour ambulatory systolic blood pressure at...
24 avr. 2019 09h00 HE | Source: Orchestra BioMed

Orchestra BioMed™ Receives FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon (SEB)

First and only non-coated sirolimus-eluting angioplasty balloon system to show promising clinical resultsPotential to offer significant advantages for treatment of coronary in-stent restenosis (ISR),...